These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Hepatoma: Tc-99m DISIDA uptake in primary and metastatic lesions. Archibeque F; Williamson MR; Rosenberg R; Eisenberg B; Davis M Clin Nucl Med; 1989 Sep; 14(9):706-7. PubMed ID: 2551557 [No Abstract] [Full Text] [Related]
7. Technetium-99m DISIDA hepatobiliary agent in diagnosis of hepatocellular carcinoma: relationship between detectability and tumor differentiation. Calvet X; Pons F; Bruix J; Bru C; Lomeña F; Herranz R; Brugera M; Faus R; Rodes J J Nucl Med; 1988 Dec; 29(12):1916-20. PubMed ID: 2848112 [TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma: uptake of 99mTc-IDA in primary tumor and metastasis. Lee VW; O'Brien MJ; Devereux DF; Morris PM; Shapiro JH AJR Am J Roentgenol; 1984 Jul; 143(1):57-61. PubMed ID: 6328961 [TBL] [Abstract][Full Text] [Related]
9. [Clinical significance of 99m Tc-HIDA scintigraphy in liver cell carcinoma and its metastatic foci]. Yasunaga T; Hirota Y; Ueno S; Tsuchigame T; Takahashi M; Beppu S Kaku Igaku; 1982 May; 19(4):523-8. PubMed ID: 6290722 [No Abstract] [Full Text] [Related]
10. Uptake of hepatobiliary agents by hepatocellular carcinoma. Vincent LM; Renner JB AJR Am J Roentgenol; 1984 Nov; 143(5):1119-21. PubMed ID: 6091431 [No Abstract] [Full Text] [Related]
11. Tc-99m HIDA hepatobiliary agent in the diagnosis of pulmonary metastasis from hepatocellular carcinoma. Wang PW; Tai DI; Chen HY Clin Nucl Med; 1991 Feb; 16(2):120-3. PubMed ID: 1848494 [TBL] [Abstract][Full Text] [Related]
12. Comparison of delayed imaging with Tc-99m PMT and Tc-99m DEIDA for visualization of hepatoma. Hasegawa Y; Nakano S; Hashizume T; Noguchi A; Ibuka K; Kasugai H; Kojima J; Ishigami S Clin Nucl Med; 1989 Jul; 14(7):526-31. PubMed ID: 2548797 [TBL] [Abstract][Full Text] [Related]